A method for predicting respiratory sarcoidosis COURSE AMID glucocorticoid therapy

摘要

method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 u0442u0435u0447u0435u043du0438u00a0 sarcoidosis of u0434u044bu0445u0430u043du0438u00a0 amid u0433u043bu044eu043au043eu043au043eu0440u0442u0438u043au043eu0438u0434u043du043eu0439 therapy by u0438u0437u0443u0447u0435u043du0438u00a0 dynamics u0440u00a0u0434u0430 u0433u0435u043cu043eu0441u0442u0430u0437u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au0438u0445 indicators before and in the process of u043bu0435u0447u0435u043du0438u00a0 u0433u043bu044eu043au043eu043au043eu0440u0442u0438u043au043eu0438u0434u0430u043cu0438, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, after u0443u0441u0442u0430u043du043eu0432u043bu0435u043du0438u00a0 diagnosis if there is testimony to the patient prior to the start of steroid therapy.in u043cu0435u0441u00a0u0446 and within a year after the beginning of therapy, the following parameters were studied u0433u043bu044eu043au043eu043au043eu0440u0442u0438u043au043eu0438u0434u043du043eu0439 u0433u0435u043cu043eu0441u0442u0430u0437u0430: partial thromboplastin u0432u0440u0435u043cu00a0 (u0430u0447u0442u0432, sec); u043fu0440u043eu0442u0440u043eu043cu0431u0438u043du043eu0432u044bu0439 index (pty); u0442u0440u043eu043cu0431u0438u043du043eu0432u043eu0435 u0432u0440u0435u043cu00a0 (tv network), u043au0430u043eu043bu0438u043du043eu0432u043eu0435 u0432u0440u0435u043cu00a0 (square, sec), fibrinogen (fg), g / l); u0444u0438u0431u0440u0438u043du043eu043bu0438u0442u0438u0447u0435u0441u043au0430u00a0 activity of blood (finger.min), antithrombin iii (at iii), protein c (pt) and their change on the background of the drs (40% Pmmax within 3 min), on the nature of u0438u0437u043cu0435u043du0435u043du0438u00a0 u0433u0435u043cu043eu0441u0442u0430u0437u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au0438u0445 indicators u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 ve u0440u043eu00a0u0442u043du043eu0441u0442u044c delayed regression of clinical and x-ray u0441u0438u043cu043fu0442u043eu043cu0430u0442u0438u043au0438 and u0440u0430u0437u0432u0438u0442u0438u00a0 residual changes in the lungs, which require a long period of u0433u043bu044eu043au043e u043au043eu0440u0442u0438u043au043eu0438u0434u043du043eu0439 and other u0440u0430u0441u0441u0430u0441u044bu0432u0430u044eu0449u0435u0439 therapy.